{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:18:37Z","timestamp":1768814317499,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1038\/sj.bjc.6600970","type":"journal-article","created":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T17:21:24Z","timestamp":1055265684000},"page":"1956-1962","source":"Crossref","is-referenced-by-count":22,"title":["Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts"],"prefix":"10.1038","volume":"88","author":[{"given":"A","family":"Sgambato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Camerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Cangiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Faraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bianchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"De Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,6,10]]},"reference":[{"key":"BF6600970_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","volume":"44","author":"C Beauchamp","year":"1971","unstructured":"Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and one assay applicable to acrylamide gels. Anal Biochem 44: 276\u2013287","journal-title":"Anal Biochem"},{"key":"BF6600970_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1128\/MCB.17.1.453","volume":"17","author":"DM Bortner","year":"1997","unstructured":"Bortner DM, Rosenberg MP (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17: 453\u2013459","journal-title":"Mol Cell Biol"},{"key":"BF6600970_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0006-291X(74)80481-X","volume":"58","author":"JS Bus","year":"1974","unstructured":"Bus JS, Aust DD, Gibson JE (1974) Superoxide- and singlet oxygen-catalyzed lipid peroxidation as a possible mechanism for paraquat (methyl viologen) toxicity. Biochem Biophys Res Commun 58: 749\u2013755","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6600970_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF01806295","volume":"17","author":"J Bustamante","year":"1990","unstructured":"Bustamante J, Galleano M, Medrano EE, Boveris A (1990) Adriamicyn effects on hydroperoxide metabolism and growth of human breast tumor cells. Breast Cancer Res Treat 17: 145\u2013153","journal-title":"Breast Cancer Res Treat"},{"key":"BF6600970_CR5","first-page":"2095","volume":"8","author":"AM Cacace","year":"1993","unstructured":"Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB (1993) The ipsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095\u20132104","journal-title":"Oncogene"},{"key":"BF6600970_CR6","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1101\/gad.10.16.1979","volume":"10","author":"BE Clurman","year":"1996","unstructured":"Clurman BE, Sheaff RJ, Thress K, Groudine M, Robertys JM (1996) Turnover of cyclin E by the ubiquitin\u2013proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10: 1979\u20131990","journal-title":"Genes Dev"},{"key":"BF6600970_CR7","first-page":"901","volume":"11","author":"M Crescimanno","year":"1991","unstructured":"Crescimanno M, D'alessandro N, Armata MG, Toulmond S, Tapiero H (1991) Modulation of the antioxidant activities in dox-sensitive and -resistant Friend leukemia cells. Effect of doxorubicin. Anticancer Res 11: 901\u2013903","journal-title":"Anticancer Res"},{"key":"BF6600970_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/nm1196-1204","volume":"2","author":"BS Croix","year":"1996","unstructured":"Croix BS, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS (1996) Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nature Med 2: 1204\u20131210","journal-title":"Nature Med"},{"key":"BF6600970_CR9","volume-title":"Cancer: Principles and Practise of Oncology","author":"VT DeVita","year":"2001","unstructured":"DeVita VT, Hellman S, Rosenberg SA (2001) Cancer: Principles and Practise of Oncology. Philadelphia: Lippincott Williams and Wilkins"},{"key":"BF6600970_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1096\/fasebj.13.8.773","volume":"13","author":"R Donnellan","year":"1999","unstructured":"Donnellan R, Chetty R (1999) Cyclin E in human cancers. FASEB J 13: 773\u2013780","journal-title":"FASEB J"},{"key":"BF6600970_CR11","first-page":"4543","volume":"43","author":"JH Doroshow","year":"1983","unstructured":"Doroshow JH (1983) Anthracycline antibiotics-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res 43: 4543\u20134551","journal-title":"Cancer Res"},{"key":"BF6600970_CR12","first-page":"309","volume":"143","author":"J Doroshow","year":"1986","unstructured":"Doroshow J (1986) Prevention of the doxorubicin induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Commun 143: 309\u2013315","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6600970_CR13","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/sj.onc.1202437","volume":"18","author":"B Eymin","year":"1999","unstructured":"Eymin B, Haugg M, Droin N, Sordet O, Dimanche-Boitrel M-T, Solary E (1999) p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 18: 1411\u20131418","journal-title":"Oncogene"},{"key":"BF6600970_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","volume":"64","author":"I Fridovich","year":"1998","unstructured":"Fridovich I (1998) Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97\u2013112","journal-title":"Annu Rev Biochem"},{"key":"BF6600970_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.cdd.4400512","volume":"6","author":"C Friesen","year":"1999","unstructured":"Friesen C, Fulda S, Debatin K-M (1999) Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ 6: 471\u2013480","journal-title":"Cell Death Differ"},{"key":"BF6600970_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000418006","volume-title":"Oxygen Radicals: Systemic Events and Disease Processes","author":"T Galeotti","year":"1990","unstructured":"Galeotti T, Borrello S, Masotti L (1990) Oxy-radical sources, scavenger systems and membrane damage in cancer cells. In Oxygen Radicals: Systemic Events and Disease Processes, Dass DK, Essman WB (eds) pp 129\u2013148. Basel: Karger"},{"key":"BF6600970_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1096\/fasebj.7.2.8440412","volume":"7","author":"K Hirose","year":"1993","unstructured":"Hirose K, Longo DL, Oppenhaim JJ, Matsuhima K (1993) Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin 1, tumor necrosis factor, selected anticancer drugs and ionizing radiation. FASEB J 7: 361\u2013368","journal-title":"FASEB J"},{"key":"BF6600970_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/jnci\/88.18.1269","volume":"88","author":"D Hochhauser","year":"1996","unstructured":"Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li W-W, Fan J, Banerjee D, Bertino JR (1996) Effects of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. J Natl Cancer Inst 88: 1269\u20131275","journal-title":"J Natl Cancer Inst"},{"key":"BF6600970_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/35030140","volume":"407","author":"P Huang","year":"2000","unstructured":"Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407: 390\u2013395","journal-title":"Nature"},{"key":"BF6600970_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.6137059","volume":"221","author":"N Kartner","year":"1983","unstructured":"Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein as associated with multidrug resistance in mammalian cell lines. Science 221: 1285\u20131288","journal-title":"Science"},{"key":"BF6600970_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnci\/84.2.113","volume":"84","author":"K Kasahara","year":"1992","unstructured":"Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijio N (1992) Determinants of the response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J Natl Cancer Inst 84: 113\u2013118","journal-title":"J Natl Cancer Inst"},{"key":"BF6600970_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/10408449309104073","volume":"23","author":"J Kehrer","year":"1993","unstructured":"Kehrer J (1993) Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23: 21\u201348","journal-title":"Crit Rev Toxicol"},{"key":"BF6600970_CR23","first-page":"380","volume":"54","author":"K Keyomarsi","year":"1994","unstructured":"Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380\u2013385","journal-title":"Cancer Res"},{"key":"BF6600970_CR24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/0092-8674(91)90044-Y","volume":"66","author":"A Koff","year":"1991","unstructured":"Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts JM (1991) Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217\u20131228","journal-title":"Cell"},{"key":"BF6600970_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/bjc.1996.451","volume":"74","author":"NH Nielsen","year":"1996","unstructured":"Nielsen NH, Arnerlov C, Emdin SO, Landberg G (1996) Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74: 874\u2013880","journal-title":"Br J Cancer"},{"key":"BF6600970_CR26","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/MCB.15.5.2612","volume":"15","author":"M Ohtsubo","year":"1995","unstructured":"Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15: 2612\u20132624","journal-title":"Mol Cell Biol"},{"key":"BF6600970_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2174\/0929867013371996","volume":"8","author":"T Owa","year":"2001","unstructured":"Owa T, Yoshino H, Yoshimatsu K, Nagasu T (2001) Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 8: 1487\u20131503","journal-title":"Curr Med Chem"},{"key":"BF6600970_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<145::AID-IJC24>3.0.CO;2-B","volume":"82","author":"B Palazzotti","year":"1999","unstructured":"Palazzotti B, Pani G, Colavitti R, De Leo ME, Bedogni B, Borrello S, Galeotti T (1999) Increased growth capacity of cervical-carcinoma cells overexpressing manganous superoxide dismutase. Int J Cancer 82: 145\u2013150","journal-title":"Int J Cancer"},{"key":"BF6600970_CR29","first-page":"4654","volume":"60","author":"G Pani","year":"2000","unstructured":"Pani G, Bedogni B, Anzevino R, Colavitti R, Palazzotti B, Borrello S, Galeotti T (2000) Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells. Cancer Res 60: 4654\u20134660","journal-title":"Cancer Res"},{"key":"BF6600970_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/38525","volume":"389","author":"K Polyak","year":"1997","unstructured":"Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300\u2013305","journal-title":"Nature"},{"key":"BF6600970_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM (1997) Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222\u2013225","journal-title":"Nat Med"},{"key":"BF6600970_CR32","first-page":"107","volume":"24","author":"C Sandhu","year":"2000","unstructured":"Sandhu C, Slingerland J (2000) Deregulation of the cell cycle in cancer. Cancer Detect Prev 24: 107\u2013118","journal-title":"Cancer Detect Prev"},{"key":"BF6600970_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1749-6632.2000.tb06710.x","volume":"910","author":"EA Sausville","year":"2000","unstructured":"Sausville EA, Johnson J, Alley M, Zaharevitz D, Senderowicz AM (2000) Inhibition of CDKs as a therapeutic modality. Ann NY Acad Sci 910: 207\u2013221","journal-title":"Ann NY Acad Sci"},{"key":"BF6600970_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1383-5718(01)00232-7","volume":"496","author":"A Sgambato","year":"2001","unstructured":"Sgambato A, Ardito R, Faraglia B, Boninsegna A, Wolf FI, Cittadini A (2001) Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage. Mut Res 496: 171\u2013180","journal-title":"Mut Res"},{"key":"BF6600970_CR35","first-page":"393","volume":"8","author":"A Sgambato","year":"1997","unstructured":"Sgambato A, Doki Y, Schieren I, Weinstein IB (1997) Effects of cyclin E overexpression on cell growth and response to TGF-\u03b2 depend on cell context and p27Kip1 expression. Cell Growth Diff 8: 393\u2013405","journal-title":"Cell Growth Diff"},{"key":"BF6600970_CR36","first-page":"1389","volume":"56","author":"A Sgambato","year":"1996","unstructured":"Sgambato A, Han EK-H, Zhou P, Schieren I, Weinstein IB (1996) Overexpression of cyclin E in the HC11 mouse mammary cell line is associated with growth inhibition and increased expression of p27Kip1. Cancer Res 56: 1389\u20131399","journal-title":"Cancer Res"},{"key":"BF6600970_CR37","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0006-2952(87)90164-X","volume":"36","author":"BK Sinha","year":"1987","unstructured":"Sinha BK, Katki AG, Batist G, Cowan KH, Myers CE (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36: 793\u2013796","journal-title":"Biochem Pharmacol"},{"key":"BF6600970_CR38","first-page":"2537","volume":"20","author":"ML Smith","year":"2000","unstructured":"Smith ML, Seo YR (2000) Sensitivity of cyclin E-overexpressing cells to cisplatin\/taxol combinations. Anticancer Res 20: 2537\u20132539","journal-title":"Anticancer Res"},{"key":"BF6600970_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/45836","volume":"401","author":"CH Spruck","year":"1999","unstructured":"Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature 401: 297\u2013300","journal-title":"Nature"},{"key":"BF6600970_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3109\/10428199809057560","volume":"30","author":"N Watanabe","year":"1998","unstructured":"Watanabe N (1998) Endogenous tumor necrosis factor and doxorubicin sensitivity in leukemic patients. Leuk Lymphoma 30: 477\u2013482","journal-title":"Leuk Lymphoma"},{"key":"BF6600970_CR41","first-page":"4319","volume":"20","author":"Q Yang","year":"2000","unstructured":"Yang Q, Sakurai T, Yoshimura G, Takashi Y, Suzuma T, Takami T, Umemura T, Nakamura Y, Nakamura M, Utsunomiya H, Mori I, Kakudo K (2000) Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C. Anticancer Res 20: 4319\u20134322","journal-title":"Anticancer Res"},{"key":"BF6600970_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s002040050118","volume":"68","author":"H Zhu","year":"1994","unstructured":"Zhu H, Bannenberg GL, Moldeus P, Shertzer HG (1994) Oxidation pathways for the intracellular probe 2\u20327\u2032-dichlorofluorescein. Arch Toxicol 68: 582\u2013587","journal-title":"Arch Toxicol"},{"key":"BF6600970_CR43","first-page":"825","volume":"54","author":"A Zyad","year":"1994","unstructured":"Zyad A, Benard J, Tursz T, Clarke R, Chouaib S (1994) Resistance to TNF-alfa and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD and TNF gene expression. Cancer Res 54: 825\u2013831","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600970","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:49:51Z","timestamp":1684414191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["BF6600970"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600970","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}